The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Scanlon Meghan since 2020.
This trader's CIK number is 1801586.
At the time of last reporting, Scanlon Meghan was the SVP,Pres,Urology Pelvic Health of Boston Scientific Corp. (stock ticker symbol BSX).
Also see all insider trading activities at Boston Scientific Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | BSX | 0 | $0 | 0 | $0 | 6,884 | $0 |
| 2021 | BSX | 0 | $0 | 30,300 | $1,347,681 | 38,390 | $608,155 |
| 2020 | BSX | 0 | $0 | 0 | $0 | 7,097 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-01 | BSX | Option Ex | 2,062 | .00 | 0 |
| 2022-02-28 | BSX | Option Ex | 1,019 | .00 | 0 |
| 2022-02-17 | BSX | Option Ex | 1,583 | .00 | 0 |
| 2022-02-18 | BSX | Option Ex | 1,112 | .00 | 0 |
| 2022-02-15 | BSX | Option Ex | 1,108 | .00 | 0 |
| 2021-07-27 | BSX | Sale | 13,850 | 45.01 | 623,388 |
| 2021-07-27 | BSX | Option Ex | 13,850 | 23.41 | 324,228 |
| 2021-07-01 | BSX | Option Ex | 855 | .00 | 0 |
| 2021-06-24 | BSX | Option Ex | 16,450 | 17.26 | 283,927 |
| 2021-06-24 | BSX | Sale | 16,450 | 44.03 | 724,293 |
| 2021-05-01 | BSX | Option Ex | 2,061 | .00 | 0 |
| 2021-02-28 | BSX | Option Ex | 1,018 | .00 | 0 |
| 2021-02-21 | BSX | Option Ex | 779 | .00 | 0 |
| 2021-02-22 | BSX | Option Ex | 1,159 | .00 | 0 |
| 2021-02-18 | BSX | Option Ex | 1,111 | .00 | 0 |
| 2021-02-15 | BSX | Option Ex | 1,107 | .00 | 0 |
| 2020-07-01 | BSX | Option Ex | 854 | .00 | 0 |
| 2020-05-01 | BSX | Option Ex | 2,061 | .00 | 0 |
| 2020-02-28 | BSX | Option Ex | 1,018 | .00 | 0 |
| 2020-02-21 | BSX | Option Ex | 778 | .00 | 0 |
| 2020-02-22 | BSX | Option Ex | 1,159 | .00 | 0 |
| 2020-02-23 | BSX | Option Ex | 1,227 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scanlon Meghan (SVP,Pres,Urology Pelvic Health of Boston Scientific Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.